Guidant Considers CRT Coverage Strategy After Study Shows Mortality Benefit
This article was originally published in The Gray Sheet
Executive Summary
Guidant plans to accelerate talks with CMS in late 2004 as it gauges whether to pursue a Medicare national coverage decision for cardiac resynchronization therapy (CRT) devices